Mersana Therapeutics
Platform to create precisely targeted and highly tailored drugs that radically improve patients’ lives. Learn more
Launch date
Employees
Market cap
€235m
Enterprise valuation
€117m (Public information from Sep 2024)
Share price
$2.19 MRSN
Cambridge Massachusetts (HQ)
Authorizing premium user...